Canopy Growth CGC
NASDAQ CGC
$1.05 +0.01 (+1.42%)
As of: Aug 20, 2026 · 3:57 PM EDT

Canopy Growth (CGC) Other Non-Current Assets (2017 - 2026)

Canopy Growth (CGC) posted Other Non-Current Assets of $12.2 million for Q1 2026, down 95.77% sequentially from $287.4 million in Q4 2025, and up 6.43% YoY from $11.4 million in Q1 2025.

Canopy Growth (CGC) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Canopy Growth has reported Other Non-Current Assets for 10 years, with the latest figure at $12.2 million in Q1 2026.

  • Quarterly Other Non-Current Assets rose 6.43% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (up 6.43% YoY) and the FY2026 annual result came in at $12.2 million, up 6.43% from the prior year.
  • Other Non-Current Assets slipped to $12.2 million in Q1 2026 per CGC's latest filing, from $287.4 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $359.0 million in Q4 2024 and troughed at $4.8 million in Q4 2022.
  • A 5-year average of $49.7 million and a median of $12.2 million in 2025 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets slumped 60.51% in 2022, then soared 1827.17% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $4.8 million in 2022, then soared by 291.34% to $18.6 million in 2023, then jumped by 1827.17% to $359.0 million in 2024, then decreased by 19.95% to $287.4 million in 2025, then plunged by 95.77% to $12.2 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $12.2 million, $287.4 million, and $12.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 56.35 Mn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 1.79 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 384.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 503.80 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 239.50 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 1.06 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 59.30 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 304.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 13.00 Mn
10 Canopy Growth 445.49 Mn 198.48 Mn 16.08 Mn 12.09 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 12.09 Mn
Mar 31, 2026 12.15 Mn
Dec 31, 2025 287.36 Mn
Sep 30, 2025 12.17 Mn
Jun 30, 2025 11.86 Mn
Mar 31, 2025 11.42 Mn
Dec 31, 2024 358.98 Mn
Sep 30, 2024 13.99 Mn
Jun 30, 2024 16.49 Mn
Mar 31, 2024 5.97 Mn
Dec 31, 2023 18.63 Mn
Sep 30, 2023 26.51 Mn
Jun 30, 2023 14.52 Mn
Mar 31, 2023 14.79 Mn
Dec 31, 2022 4.76 Mn
Sep 30, 2022 11.12 Mn
Jun 30, 2022 11.34 Mn
Mar 31, 2022 12.11 Mn
Dec 31, 2021 12.05 Mn
Sep 30, 2021 7.12 Mn